Puerta de Hierro

Madrid 28220

1 studies enrolling now · 2 studies all time

What they study most

Her2 Negative Breast Cancer Patients, Tricuspid Regurgitation

Studies at this site

• Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment — Enrolling by invitation
• Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer — Completed